Jefferies starts Elis at “buy,” sees strong growth and capital upside

Published 03/06/2025, 12:16
© Reuters.

Investing.com -- Jefferies has initiated coverage of Elis (HE:ELISA) with a “buy” rating and a €30 price target, the highest on the street. 

The brokerage points to the company’s resilient business model and a defined medium-term growth outlook, supported by a stronger balance sheet and disciplined execution.

Elis generates about 85% of its revenue from rental and maintenance services for linens and workwear, with roughly 30% of that tied to the healthcare sector.

Jefferies says this defensive mix, coupled with a proven management track record, helped the company maintain profitability and cash flow during the COVID-19 pandemic. 

The analysts also flag structural industry drivers such as increased outsourcing and room for market consolidation.

The balance sheet has improved meaningfully, with net debt to EBITDA falling from more than 3x in earlier years to 1.85x in fiscal 2024. 

Jefferies notes this enhances Elis’s defensive profile and positions it to pursue bolt-on acquisitions without adding leverage.

The brokerage forecasts a compound annual growth rate of about 7% in adjusted earnings per share from 2024 to 2027. 

That projection includes around 4% organic revenue growth, evenly split between volume and pricing. 

Operating margins are expected to improve by roughly 20 basis points annually from 35.2% in 2024, helped by the rollout of cost initiatives modeled after the company’s operations in France. 

Jefferies points to Elis’s high market density, penetration of small and midsize businesses, and cross-selling efforts as further margin drivers. Easing inflation could also support profitability, according to Jefferies’ internal cost tracker.

Jefferies also cites a shift in capital allocation policy as a potential upside catalyst. With debt levels reduced, Elis plans to maintain its focus on acquisitions while introducing shareholder returns as part of its financial strategy. 

The analysts estimate the company could have about €500 million in balance sheet capacity by 2027, potentially allowing for €100 million annually in buybacks or special dividends. This would imply a total yield of roughly 4%.

Despite these developments, the stock trades at around 12 times Jefferies’ estimated 2026 earnings, in line with its historical average. 

The brokerage argues this valuation does not fully reflect the improved operating and financial profile.  Jefferies notes that consistent delivery on earnings growth targets could support multiple expansion. 

Key risks include macroeconomic pressure, increased competition, and renewed inflationary headwinds.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.